Novel pharmacological activity for R-ketorolac in ovarian cancer
(HealthDay)—The R-enantiomer of ketorolac is enriched in peritoneal fluids and inhibits peritoneal cell GTPase activity with administration after ovarian cancer surgery, according to a study published online June 12 in ...
Aug 4, 2015
0
8